During the past decade, Ramon L. Ortega Colon conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ramon L. Ortega Colon" are "Rheumatoid Arthritis" (2 trials) and "Lupus Erythematosus, Systemic" (1 trials). Many other conditions were trialed in "Ramon L. Ortega Colon" in a lesser frequency.

Most popular intervention types in "Ramon L. Ortega Colon" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Baricitinib" (2 trials), "Adalimumab" (1 trials), "Adalimumab Placebo" (1 trials), "Baricitinib Placebo" (1 trials) and "Methotrexate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ramon L. Ortega Colon" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Ramon L. Ortega Colon". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ramon L. Ortega Colon, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ramon L. Ortega Colon, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".